CancerWorld shared a post on LinkedIn:
“CancerWorld Issue #115 (May) is live!
What does progress in oncology really mean – when science advances faster than health systems can deliver it?
May issue of CancerWorld explores this tension between discovery and delivery:
Between what is possible in the lab and what is actually reaching patients in the real world.
From Rwanda’s bold “Mission 2027” to eliminate cervical cancer ahead of global targets – led by Dr Sabin Nsanzimana, who is turning global ambition into a national system defined by urgency and execution – to advances in immunotherapy, RAS-targeted approaches in pancreatic cancer, and emerging insights into treatment timing through circadian biology – this issue shows oncology at a pivotal moment.
We also reflect on the legacy of Dr Charles Balch, whose work has helped define surgical oncology and shape the global architecture of cancer care. His career is a reminder that progress is not only about scientific breakthroughs, but about the systems, standards, and institutions that allow innovation to endure – and reach patients everywhere.
But a deeper question runs through every story:
How do we ensure progress is not just achieved, but shared?
Also featured:
- Survivorship as a growing but under-supported phase of care.
- The importance of palliative care and dignity in advanced illness.
- The gap between scientific innovation and real-world access.
- The evolving ecosystem of cancer research, policy, and delivery.
Oncology is advancing rapidly – but its true impact depends on systems, equity, and execution.
Read the full issue and join the conversation shaping the future of cancer care”
Other articles featuring CancerWorld on OncoDaily.